Management of neuritis in leprosy.
D000814:Aniline Compounds / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D006801:Humans; D007097:Imines / Q000627:therapeutic use; D007918:Leprosy / Q000150:complications* / Q000188:drug therapy; D009443:Neuritis / Q000150:complications / Q000188:drug therapy*; D010619:Phenazines / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D007097:Imines; D010619:Phenazines; D011241:Prednisone